Issue 38, 2023

Retraction: A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer

Abstract

Retraction of ‘A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer’ by Nuernisha Alifu et al., J. Mater. Chem. B, 2022, 10, 506–517, https://doi.org/10.1039/D1TB02481G.

Associated articles

Article information

Article type
Retraction
Submitted
20 Sep 2023
Accepted
20 Sep 2023
First published
26 Sep 2023
This article is Open Access
Creative Commons BY license

J. Mater. Chem. B, 2023,11, 9311-9311

Retraction: A novel TMTP1-modified theranostic nanoplatform for targeted in vivo NIR-II fluorescence imaging-guided chemotherapy for cervical cancer

N. Alifu, R. Ma, L. Zhu, Z. Du, S. Chen, T. Yan, G. Alimu, L. Zhang and X. Zhang, J. Mater. Chem. B, 2023, 11, 9311 DOI: 10.1039/D3TB90178E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements